{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:20:31Z","timestamp":1790014831231,"version":"4.0.1"},"reference-count":53,"publisher":"Informa UK Limited","issue":"9","funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK117058"],"award-info":[{"award-number":["K23DK117058"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Immunology"],"published-print":{"date-parts":[[2019,9,2]]},"DOI":"10.1080\/1744666x.2019.1646127","type":"journal-article","created":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T06:53:51Z","timestamp":1563519231000},"page":"969-979","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":81,"title":["Overall and comparative safety of biologic and immunosuppressive therapy in inflammatory bowel diseases"],"prefix":"10.1080","volume":"15","author":[{"given":"Ariela","family":"Holmer","sequence":"first","affiliation":[{"name":"University of California San Diego","place":["La Jolla, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Singh","sequence":"additional","affiliation":[{"name":"University of California San Diego","place":["La Jolla, USA"]},{"name":"University of California San Diego","place":["La Jolla, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,7,25]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.02.015"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.218"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.433"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.294"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.791"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804647"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMct1209614"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.04.039"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12499"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21697"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12930"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izx072"},{"key":"e_1_3_4_15_1","first-page":"680","article-title":"Five-year safety data from ENCORE, a European observational safety registry for adults with Crohn\u2019s disease treated with infliximab [Remicade(R)] or Conventional Therapy","volume":"11","author":"D\u2019Haens G","year":"2017","unstructured":"D\u2019Haens G, Reinisch W, Colombel JF, et al. Five-year safety data from ENCORE, a European observational safety registry for adults with Crohn\u2019s disease treated with infliximab [Remicade(R)] or Conventional Therapy. J Crohns Colitis. 2017;11:680\u2013689.","journal-title":"J Crohns Colitis"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0098-4"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.04.012"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h2809"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1692"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.02.044"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.479"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(18)30684-X"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.01.012"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.12.032"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0546-0"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316023"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215734"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-311079"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy153"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izx097"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.09.035"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.236"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062382"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602773"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14794"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12214"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.10.005"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.08.034"},{"key":"e_1_3_4_39_1","first-page":"706","article-title":"Safety surveillance for ustekinumab and other psoriasis treatments from the psoriasis longitudinal assessment and registry (PSOLAR)","volume":"14","author":"Papp K","year":"2015","unstructured":"Papp K, Gottlieb AB, Naldi L, et al. Safety surveillance for ustekinumab and other psoriasis treatments from the psoriasis longitudinal assessment and registry (PSOLAR). J Drugs Dermatol. 2015;14:706\u2013714.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606910"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.11.035"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1866-2"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.05.024"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.12.052"},{"key":"e_1_3_4_45_1","first-page":"A1542","article-title":"Real-world data from a post-approval safety surveillance study of tofacitinib vs biologic dmards and conventional synthetic dmards: five-year results from a US-based rheumatoid arthritis registry","volume":"70","author":"Kremer JCL","year":"2018","unstructured":"Kremer JCL, Etzel CJ, Greenberg J, et al. Real-world data from a post-approval safety surveillance study of tofacitinib vs biologic dmards and conventional synthetic dmards: five-year results from a US-based rheumatoid arthritis registry. Arthritis Rheumatol. 2018;70:A1542.","journal-title":"Arthritis Rheumatol"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.12.025"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.5613"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.16071"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw048"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.04.033"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.05.004"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.181"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-019-00797-3"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.07.013"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15752"}],"container-title":["Expert Review of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1744666X.2019.1646127","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T08:12:52Z","timestamp":1754899972000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1744666X.2019.1646127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,25]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9,2]]}},"alternative-id":["10.1080\/1744666X.2019.1646127"],"URL":"https:\/\/doi.org\/10.1080\/1744666x.2019.1646127","relation":{},"ISSN":["1744-666X","1744-8409"],"issn-type":[{"value":"1744-666X","type":"print"},{"value":"1744-8409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-05-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}